Abbott Laboratories (ABL)
FSX
Closed
Oct 7, 2026
Day's Range
87.0052 wk Range
69.76Overview - ABL - Abbott Laboratories
Key Statistics
Valuation
Enterprise Value
156.35B
P/E (Trailing)
‪32.21‬
P/E (Forward)
‪18.38‬
PEG Ratio
‪-0.66‬
Price / Sales (TTM)
‪3.18‬
Price / Book
‪3.28‬
EV / EBITDA
‪15.07‬
Profitability
Profit Margin
‪11.64%‬
Operating Margin
‪14.70%‬
Return on Assets
‪5.32%‬
Return on Equity
‪10.57%‬
Ownership
Shares Outstanding
1.73B
Float
1.71B
Held by Insiders
‪0.49%‬
Held by Institutions
‪81.78%‬
Price stats
Beta
‪0.58‬
50-Day Avg
‪92.79‬
200-Day Avg
‪88.82‬
Dividends
Payout Ratio
‪78.71%‬
Frequency
Quarterly
Market Cap - ABL - Abbott Laboratories
Peers - ABL - Abbott Laboratories
Peer Comparison
Compared with companies in Medical Devices listed on FSX.
Profile Summary - ABL - Abbott Laboratories
About
Abbott Laboratories is a global healthcare company that develops, manufactures, and markets a broad range of medical products and solutions. Abbott Laboratories operates across four core segments: established pharmaceutical products, diagnostic products, nutritional products, and medical devices. Its portfolio…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
